CIITA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CIITA monoclonal antibodies for research focused on understanding the Class II Transactivator (CIITA) in immune response regulation. CIITA Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIITA functions as a transcription factor that regulates the expression of Major Histocompatibility Complex (MHC) class II genes, playing a vital role in the adaptive immune response. By facilitating the presentation of antigens to CD4+ T cells, CIITA is essential for the activation of immune responses against pathogens. Understanding CIITA function provides valuable insights into immune system disorders and potential therapeutic targets. Researchers can explore immune regulation mechanisms through precise detection and analysis of CIITA expression patterns. Advanced visualization techniques enable detailed examination of CIITA localization and interactions within cellular compartments. Comprehensive characterization of CIITA activity supports the development of targeted therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing immunology research and therapeutic development through reliable, specific detection of CIITA.